Our Story
Welcome to the Infectious Disease and Drug Discovery (IDDD) Lab at Texas Southern University, where groundbreaking science meets real-world impact
The IDDD Lab at Texas Southern University is a leading research initiative focused on the discovery and development of new treatments for infectious diseases. As part of TSU’s College of Pharmacy and Health Sciences, we combine translational science, and training of the next generation of biomedical researchers.
Mission
To develop next-generation therapeutics targeting infectious diseases that disproportionately impact underserved communities.
Vision
To be a national hub for discovery and innovation in infectious disease research.
Meet the Principal Investigator
"At IDDD, we believe drug discovery should reflect the communities it serves. We are proud to lead cutting-edge research and inclusive training that advances science and social impact."
Dr. Omonike Olaleye, PI
Infectious Diseases and Drug Discovery (IDDD) Lab,
Senior Associate Vice President for Research and Innovation,
Texas Southern University
Research Focus Areas
Tuberculosis (TB)
Developing inhibitors for drug-resistant Mycobacterium tuberculosis.
HIV/AIDS
Novel integrase and protease inhibitors using molecular modeling
COVID-19 & Coronaviruses
Small molecule antivirals and spike protein neutralizers
Antimicrobial Resistance (AMR)
Investigating β-lactamase inhibitors and resistance mechanisms.
Quick Facts
Pubications
10+ peer-reviewed papers since 2020
Research
$7.8M in active research funding